Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Cancer immunotherapies should be developed in Vienna

Cancer © Photo: APA (Hochmuth)

"Boehringer Ingelheim invests about EUR 200 million each year in non-clinical and clinical research“, said Philipp von Lattorff, CEO of the regional center for the German pharmaceutical giant in Vienna, which is responsible for 33 countries. He was speaking at a press conference to commemorate the opening of the new research building, built at a cost of about EUR 19 million. It offers space for 80 employees working in the field of immunology.  

The search for new immunotherapeutics to combat cancer is to be intensified in Vienna. According to Darryl McConnell, who heads the research facility in Vienna, the underlying mission following the attack on the “Achilles heel” of tumor cells based on target-oriented therapies is to take away the “caps of invisibility” of these malignant cells, which protect them against the body’s own immune system.

The first such therapies with monoclonal antibodies (checkpoint inhibitors) are already allowed in the case of advanced melanoma and some types of lung cancer. Long-term efficiency only exists at present with about 20 percent of the patients and can thus be significantly improved, for example by means of new, small-sized synthetic active-ingredient molecules, therapeutic monoclonal antibodies and/or anti-cancer vaccines.

The Boehringer-Ingelheim Group has bundled its cancer research in Vienna since the year 2000. Moreover, an additional EUR 20 million is made available to provide basic financing for the Institute for Molecular Pathology (IMP). The new, recently constructed faculty building at IMP cost approximately EUR 50 million.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us at: “Austrian Business Circle”

    03.09.2018, St. Petersburg, Russia

  • Meet us at: Turkmenistan - Heart of the Great Silk Road

    05./06.09.2018, Hotel Savoyen Vienna, Rennweg 16, 1030 Vienna

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

Logo
More testimonials

news from the business location Austria

Chemical bonding simulated with a quantum computer

An international research group has carried out the world’s first quantum-chemical simulation on an ion-trapped quantum computer.

From Mixed Reality to Smart Factory – Austria Shapes the Digital Future of Work

New types of technologies are revolutionizing everyday work in the industrial sector. Methods and processes of industrial production in the future are being re-modelled in digital pilot factories. Austria has long been one of the most important providers of impetus in this dawning industrial age.

More news All blog posts